TIAP
Overview
TIAP specializes in venture building of early-stage health science technologies emerging from its academic members. It transforms early-stage scientific innovations into business ventures, de-risks ideas through expert financial and scientific advice, invests in early-stage innovations and sources external venture capital for future funding, and leverages its extensive global and local network to create links between industry, researchers, investors and Members.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Radiant Biotherapeutics | Sep 2024 | Series A | Co-investor |
| Notch Therapeutics | Nov 2019 | Seed | Co-investor |
| TrendMD | May 2014 | Seed | Co-investor |
| ODAIA | Sep 2019 | Seed | Co-investor |
| HDAX Therapeutics | Sep 2024 | Seed | Lead |
For institutional investors. Book with your work email.
Key People
Michael Wasserman
Member Board of Directors, Chair, Investment Committee
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is TIAP based?
TIAP is headquartered in Toronto, Ontario, Canada.
When was TIAP founded?
TIAP was founded in 2008.
How many portfolio companies does TIAP have?
TIAP has 41 portfolio companies in Caplight's dataset.
What are some companies in TIAP's portfolio?
Portfolio companies visible on Caplight include Radiant Biotherapeutics, Notch Therapeutics, TrendMD, ODAIA, HDAX Therapeutics.
What was TIAP's most recent investment shown here?
TIAP's most recent investment in this portfolio sample was in Radiant Biotherapeutics in 2024.
What sectors does TIAP focus on?
TIAP focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, FinTech, Cybersecurity, Healthcare & Life Sciences, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Cybersecurity, Enterprise Software, Media, Entertainment & Gaming, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure.
What company stages does TIAP focus on?
TIAP typically invests at the Early stage.
What is TIAP's AUM?
TIAP's assets under management are estimated between $100.0M and $250.0M.